Finding effective, medically supervised weight loss support in Northern Ireland has historically meant long waiting lists, limited NHS services, and frustrating eligibility barriers. For many people across Belfast, Derry, Lisburn, Newry, and beyond, the gap between needing help and actually getting it has been painfully wide.
That is changing. A new generation of prescription weight loss medications, known as GLP-1 receptor agonists, has transformed what is clinically achievable. Medications like Mounjaro (tirzepatide) and Wegovy (semaglutide) are producing average weight losses of 15% to 22.5% of body weight in clinical trials, results that were previously only associated with bariatric surgery. And thanks to online clinics regulated to the same standards as traditional healthcare providers, patients anywhere in Northern Ireland can now access these treatments without leaving home.
This guide explains what medical weight loss options are available in Northern Ireland, how online clinics work, what to expect from GLP-1 treatment, and how to get started safely.
The Weight Management Challenge in Northern Ireland
Northern Ireland has some of the highest rates of overweight and obesity in the United Kingdom. According to the Department of Health NI, approximately 65% of adults in Northern Ireland are classified as overweight or obese. Despite this, access to specialist weight management services remains limited compared to other parts of the UK.
NHS Weight Management Services in NI
The NHS in Northern Ireland operates a tiered approach to weight management:
- Tier 1 and 2: Community-based lifestyle interventions, dietary advice, and exercise programmes. These are relatively accessible but often insufficient for patients with clinically significant obesity.
- Tier 3: Specialist multidisciplinary weight management services. These are limited in availability across Northern Ireland, with long waiting lists that can stretch to 12 months or more in some Health and Social Care Trust areas.
- Tier 4: Bariatric surgery. Access in Northern Ireland is extremely restricted, with strict BMI criteria (typically BMI 40+ or BMI 35+ with serious comorbidities) and waiting times that can extend to several years.
For the majority of patients who fall between lifestyle advice and surgery, there has been a significant gap in available treatment. GLP-1 medications like Mounjaro and Wegovy sit precisely in this gap, offering substantial weight loss without the risks and recovery time associated with surgical intervention.
Why NHS Prescribing of GLP-1 Medications Is Limited in NI
While NICE has approved both Wegovy and Mounjaro for weight management, the rollout across NHS services in Northern Ireland has been slow. Budget constraints, commissioning decisions, and the limited capacity of specialist weight management teams mean that NHS prescribing of these medications in NI remains uncommon. Most patients who want access to GLP-1 treatment in Northern Ireland currently need to go through a private prescriber.
The GLP-1 Revolution: How These Medications Work
GLP-1 receptor agonists represent the most significant advance in medical weight management in decades. To understand why they are so effective, it helps to understand the biology behind them.
GLP-1 (glucagon-like peptide-1) is a hormone your body produces naturally in response to eating. It plays several important roles:
- Appetite regulation: GLP-1 signals your brain that you are full, reducing hunger and making it easier to eat less without feeling constantly deprived.
- Gastric emptying: It slows the rate at which food leaves your stomach, helping you feel satisfied for longer after meals.
- Blood sugar control: GLP-1 helps regulate insulin release, which stabilises blood sugar levels and reduces cravings.
The prescription medications mimic and amplify these natural effects. They are administered as a once-weekly injection using a simple pre-filled pen, similar to the devices used for insulin.
Mounjaro (Tirzepatide)
Mounjaro is manufactured by Eli Lilly and works as a dual GIP and GLP-1 receptor agonist. This means it activates two gut hormone pathways rather than one, which is thought to be responsible for its particularly strong weight loss results. In the SURMOUNT-1 clinical trial, participants on the highest dose of Mounjaro lost an average of 22.5% of their body weight over 72 weeks.
For more detailed information about Mounjaro, including dosing, side effects, and how to get prescribed in Northern Ireland, read our dedicated guide: Mounjaro in Northern Ireland.
Wegovy (Semaglutide)
Wegovy is manufactured by Novo Nordisk and works as a GLP-1 receptor agonist. It has a well-established clinical track record and demonstrated cardiovascular benefits beyond weight loss. In the STEP clinical trials, participants on Wegovy lost an average of approximately 15% of their body weight at the standard 2.4 mg dose.
For a comprehensive guide to Wegovy in Northern Ireland, including costs and the prescribing process, see our full article: Wegovy in Northern Ireland.
Who Is Eligible for GLP-1 Weight Loss Treatment?
The eligibility criteria for prescription weight loss medications in the UK follow guidelines set by NICE (the National Institute for Health and Care Excellence). To be considered for treatment with Mounjaro or Wegovy, you generally need to meet one of the following criteria:
- BMI of 30 or higher (classified as obesity), or
- BMI of 27 or higher with at least one weight-related health condition, such as type 2 diabetes, high blood pressure, high cholesterol, polycystic ovary syndrome (PCOS), or obstructive sleep apnoea.
Additional requirements typically include:
- Being aged 18 or over
- Having tried lifestyle changes (diet and exercise) without achieving sufficient weight loss
- No contraindications to GLP-1 medications (such as a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2)
- Not currently pregnant, breastfeeding, or planning pregnancy in the near future
If you are unsure whether you meet the criteria, you can complete our free online eligibility questionnaire. It takes just a few minutes and will tell you whether you are likely to be suitable for treatment.
Why Northern Ireland Patients Are Choosing Online Weight Loss Clinics
The shift towards online healthcare is not about replacing traditional medical care. It is about filling a gap that exists right now for patients in Northern Ireland who need help but cannot access it through conventional channels. Here is why online weight loss clinics have become the practical choice for many NI patients:
1. No Waiting Lists
Unlike NHS specialist services, where you may wait months or even years for an appointment, online clinics can typically begin the consultation process within days. For patients in Northern Ireland who have already spent months trying to get a referral, this difference is significant.
2. Access From Anywhere in NI
Whether you live in central Belfast, rural County Fermanagh, on the Causeway Coast, or anywhere in between, an online clinic provides the same level of care. You do not need to travel to a specific hospital or clinic, take time off work, or arrange childcare. Your consultation happens from home, and your medication is delivered to your door.
3. Specialist Prescribers
Good online clinics employ prescribers who specialise in weight management and are experienced with GLP-1 medications. This is important because these medications require proper assessment, appropriate dose titration, and ongoing monitoring, which a general practitioner may not have extensive experience with.
4. Ongoing Support and Monitoring
Medical weight loss is not a one-off prescription. Effective treatment involves regular check-ins, dose adjustments, side effect management, and lifestyle guidance. Online clinics are well set up to provide this ongoing support through regular remote consultations.
RQIA Regulation: What It Means for NI Patients
When choosing any healthcare provider, whether online or in person, regulation is the most important factor to check. In Northern Ireland, healthcare services are regulated by the RQIA (Regulation and Quality Improvement Authority).
Evernu is RQIA-regulated, which means we are held to the same standards of clinical governance, patient safety, and quality of care as any traditional healthcare provider in Northern Ireland. This includes:
- Clinical oversight: All prescribing decisions are made by qualified, registered clinicians who follow established clinical guidelines.
- Patient safety: Proper medical assessments before prescribing, appropriate eligibility screening, and ongoing monitoring throughout treatment.
- Data protection: Your medical information is handled in accordance with UK data protection legislation.
- Accountability: As a regulated service, we are subject to inspection and must maintain standards set by the RQIA.
This matters because the weight loss medication market has attracted providers of varying quality. Some operate from outside the UK and may not be subject to the same regulatory standards. Choosing an RQIA-regulated provider gives you the assurance that your treatment is being managed to the standards required of healthcare providers in Northern Ireland.
How the Process Works: From Questionnaire to Treatment
Getting started with medical weight loss through an online clinic is straightforward. Here is how the process works at Evernu:
Step 1: Complete the Online Questionnaire
Our medical eligibility questionnaire asks about your health history, current medications, weight loss goals, and lifestyle. It is designed to identify whether GLP-1 treatment is safe and appropriate for you. The questionnaire typically takes 5 to 10 minutes to complete.
Step 2: Clinical Review
Your questionnaire responses are reviewed by one of our prescribing clinicians. They assess your medical suitability, check for contraindications, and determine which medication and starting dose is most appropriate for your individual circumstances.
Step 3: Consultation
If further information is needed, or if your medical history requires more detailed discussion, a clinician will arrange a remote consultation with you. This gives you the opportunity to ask questions, discuss your goals, and ensure you are fully informed about the treatment.
Step 4: Prescription and Delivery
Once approved, your prescription is dispensed by a registered pharmacy, and your medication is delivered directly to your home anywhere in Northern Ireland. Medications that require cold chain storage (like GLP-1 injections) are shipped in temperature-controlled packaging to ensure they arrive safely.
Step 5: Ongoing Monitoring
Treatment does not end with the first prescription. Our clinical team monitors your progress, adjusts your dose as needed during the titration period, manages any side effects, and provides ongoing support to help you get the best possible results.
What Results Can You Expect?
It is important to set realistic expectations. While the clinical trial data is impressive, individual results vary based on factors including starting weight, metabolic health, medication type and dose, and adherence to lifestyle changes alongside the medication.
Here is what the clinical evidence shows:
| Medication | Average Weight Loss | Trial Duration |
|---|---|---|
| Mounjaro 5 mg | 15% of body weight | 72 weeks |
| Mounjaro 10 mg | 19.5% of body weight | 72 weeks |
| Mounjaro 15 mg | 22.5% of body weight | 72 weeks |
| Wegovy 2.4 mg | 15% of body weight | 68 weeks |
In practical terms, for a patient starting at 100 kg (approximately 15 stone 10 lbs), this translates to a potential weight loss of 15 kg to 22.5 kg over the treatment period. Most patients begin to notice meaningful weight loss within the first 4 to 8 weeks of treatment, with results continuing to accumulate over the following months as the dose is gradually increased.
Beyond the numbers on the scale, patients commonly report improvements in blood pressure, blood sugar levels, cholesterol, joint pain, energy levels, sleep quality, and overall quality of life.
Costs of GLP-1 Treatment in Northern Ireland
As GLP-1 medications are predominantly accessed through private prescribers in Northern Ireland, cost is an important consideration. Prices vary between providers and can change as wholesale medication costs fluctuate. At the time of writing, you can generally expect to pay in the region of:
- Mounjaro: Starting doses are typically less expensive, with costs increasing as you titrate to higher doses. Monthly costs generally range from approximately £130 to £250+ depending on the dose level.
- Wegovy: Monthly costs are broadly similar, typically ranging from approximately £150 to £250 depending on the dose.
These costs typically include the medication itself, clinical review, and ongoing monitoring. It is worth asking any provider exactly what is included in their pricing to avoid unexpected charges.
While these are significant monthly costs, many patients find that they are comparable to or less than what they were previously spending on diet programmes, gym memberships, supplements, and other weight loss products that were not delivering results. The key difference is that GLP-1 medications have robust clinical evidence behind them.
Safety and Side Effects
Like all prescription medications, GLP-1 treatments can cause side effects. The most common are gastrointestinal in nature and tend to be most noticeable during the early weeks of treatment and when the dose is increased:
- Nausea: The most frequently reported side effect. Usually mild to moderate and improves as your body adjusts to the medication.
- Reduced appetite: This is partly how the medication works, but it can feel pronounced initially.
- Constipation or diarrhoea: Digestive changes are common in the first few weeks.
- Fatigue: Some patients report tiredness, particularly during dose increases.
- Injection site reactions: Mild redness or discomfort at the injection site, which typically resolves quickly.
For most patients, these side effects are manageable and diminish over time. The gradual dose titration schedule (starting at a low dose and increasing slowly over several weeks) is specifically designed to minimise side effects and give your body time to adjust.
Serious side effects are rare but can include pancreatitis, gallbladder problems, and allergic reactions. Your prescribing clinician will discuss these risks with you before treatment begins and will monitor for any warning signs throughout your treatment.
How Evernu Serves Patients Across Northern Ireland
We established our service with a specific focus on making high-quality weight management care accessible to patients who have been underserved by existing NHS provision. Our clinicians treat patients from across Northern Ireland, including Belfast, Derry/Londonderry, Lisburn, Newry, Bangor, Craigavon, Ballymena, Omagh, Enniskillen, Coleraine, and all surrounding areas.
Because our consultations are conducted remotely and medications are delivered to your door, your location within Northern Ireland makes no difference to the quality of care you receive. Whether you live in a city centre or a rural community, you have access to the same specialist prescribers, the same medications, and the same ongoing support.
As an RQIA-regulated service, we meet the regulatory standards required of healthcare providers operating in Northern Ireland. This is not a detail we mention casually. It is a commitment to patient safety and clinical quality that underpins everything we do.
How to Get Started
If you are considering medical weight loss treatment and you live in Northern Ireland, here is how to take the first step:
- Check your eligibility: Complete our free online questionnaire. It takes a few minutes and will tell you whether you are likely to be suitable for GLP-1 treatment based on your BMI, medical history, and current health.
- Review your options: If you are eligible, our clinical team will review your information and recommend the most appropriate medication and starting dose for your individual circumstances.
- Start treatment: Once approved, your medication is prescribed and delivered to your home. You will receive clear instructions on how to administer your injection and what to expect in the early weeks.
- Ongoing support: Regular check-ins with our clinical team ensure your dose is optimised, any side effects are managed, and you are making progress towards your goals.
You can also explore our weight loss treatment page for more detailed information about the medications we prescribe and the support we provide.
Frequently Asked Questions
Do I need a referral from my GP?
No. You do not need a GP referral to access treatment through Evernu. Our clinicians carry out a full medical assessment as part of the prescribing process. However, we do recommend informing your GP that you are taking a GLP-1 medication, as it is good practice for your GP to have a complete picture of your healthcare.
How quickly can I start treatment?
Most patients can complete the eligibility assessment and clinical review process within a few days. Once approved, medication is typically delivered within 3 to 5 working days anywhere in Northern Ireland.
Can I switch between Mounjaro and Wegovy?
Yes, in some cases. If one medication is not suiting you, whether due to side effects, availability, or effectiveness, your prescribing clinician can discuss switching to the alternative. This is done with appropriate medical supervision and dose adjustment.
Is the treatment long-term?
GLP-1 medications are most effective when used as part of a long-term weight management plan. Research shows that weight regain is common if the medication is stopped without establishing sustainable lifestyle changes. Your clinician will work with you on a plan that supports lasting results, which may include dose adjustment or transition strategies over time.
What if I have other health conditions?
Many patients who are eligible for GLP-1 treatment have existing health conditions such as type 2 diabetes, high blood pressure, or high cholesterol. In many cases, weight loss with GLP-1 medications can actually improve these conditions. Our clinicians will take your full medical history into account when assessing your suitability and will monitor for any interactions with your existing medications.
Taking the Next Step
Living with obesity is not a matter of willpower. It is a complex medical condition influenced by genetics, hormones, metabolism, and environment. The arrival of GLP-1 medications has given patients in Northern Ireland a genuinely effective treatment option, one that works with your biology rather than against it.
If you have been struggling with your weight and have not found success with diet and exercise alone, medical treatment may be the right next step. Our free eligibility questionnaire is the simplest way to find out whether GLP-1 treatment could work for you. It takes just a few minutes, and there is no obligation to proceed.
You deserve access to the same quality of care regardless of where you live in Northern Ireland. That is exactly what we are here to provide.
